Search
Powered By HealthLine
Special Offers
Health Tools
 Pregnancy Q&A
 Birth Control Options
 Mom's Diary of the First Weeks
 Baby Due Date Calculator
 Fertilization Summary
Featured Conditions
 Menopause
 Sexual Health
 Breast Cancer
 Skin Care
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Cow's Milk Protein Could Help Save Preemies' Lives

Lactoferrin cut blood infections by about two-thirds, study found

By Serena Gordon
HealthDay Reporter


Related Encyclopedia
 border=
Acne
AIDS and HIV Infection
Alagille Syndrome
Amenorrhea
More...

Related Healthscout Videos
 border=
Sports: Play Younger, Play Longer
Fixing Babies' Heads
Removing Tumors Through the Nose
Saving Kids' Eyes: Retinoblastoma
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Dental Cavities
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Adderal XR
Cialis
Concerta
More...

Related News Articles
 border=
Absent Father Might Mean Earlier Puberty for Higher-Income Girls
Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure
Most Suicidal Teens Seen in ER Receive Follow-up Care
Kids With Allergies Shouldn't Skip Flu Shots, Experts Say
More...

TUESDAY, Oct. 6 (HealthDay News) -- A protein from cow's milk could reduce by about two-thirds the rate of serious blood infections in babies born weighing less than 3.3 pounds.

That's the conclusion of a study published in the Oct. 7 issue of the Journal of the American Medical Association that found when these tiny newborns were given a daily dose of the milk protein lactoferrin along with a probiotic bacteria during the first weeks of life, the incidence of the blood infection sepsis dropped dramatically.

Text Continues Below



"Prevention of sepsis in neonates can be achieved through supplementation of a simple, easily available, cost-effective intervention that is well-tolerated and may be implemented in all settings, including Third World [countries]," said study author Dr. Paolo Manzoni, a neonatologist at S. Anna Hospital in Torino, Italy.

However, when isolated from milk and then concentrated -- as it was in this study -- bovine lactoferrin is not yet approved for use in the United States.

"The biggest hurdle if I was to use this, is that it's not FDA-approved," said the author of an accompanying editorial in the same issue of the journal, Dr. David Kaufman, assistant medical director of the neonatal intensive care unit at the University of Virginia Medical School in Charlottesville.

"Preventive strategies in these infants are really critical. Many preterm babies don't survive because of infection. I hope this treatment gets fast-tracked for approval, because this is a big effect from what seems like a safe and minimal intervention," said Kaufman.

Because bovine lactoferrin is naturally found in cow's milk, Manzoni said the researchers don't expect any long-term safety problems. Lactoferrin is also found in breast milk, but because of the concentrations needed, has to be genetically engineered, making it more expensive, according to Manzoni.

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 10/6/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Paolo Manzoni, M.D., neonatalogist, S. Anna Hospital, and coordinator, Italian Network for the Study of Neonatal Infections, and, chairman, scientific committee, Neonatalogy Foundation, S. Anna Hospital, Torino, Italy; David Kaufman, M.D., associate professor, pediatrics, assistant medical director, neonatal intensive care unit, and director, the Neonatal Clinical Trials Unit, University of Virginia Medical School, Charlottesville, Va.; Oct. 7, 2009, Journal of the American Medical Association


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy